News

CRO Accovion rolls into Italy with eyes on France

German-headquartered CRO Accovion is expanding its reach in Europe, opening a new shop in Italy and planning to launch a French subsidiary in the fall.

Amid global expansion, India's GVK focuses on clinical development

Indian CRO GVK Biosciences has spent the last year transitioning from a discovery-focused contractor to a full-service developer, now launching a dedicated clinical research unit to reach drugmakers around the world.

Theorem eyes an Indian expansion with latest partnership

CRO Theorem Clinical Research has inked a deal with India's Excel Life Sciences to broaden its footprint in the country, expanding its access to clinical trial sites and bolstering its patient-recruitment capabilities.

Post-buyout Harlan inks a CRO partnership with Fluofarma

Months removed from getting bought by Huntingdon Life Sciences, Harlan Laboratories has teamed up with a French CRO to expand its capabilities in drug discovery and translational medicine.

CRO Chiltern snags rival Ockham to bolster its oncology footprint

Chiltern has acquired Ockham, a fellow contract researcher, planning to absorb the company's capabilities and expand its service offerings.

Catalent shoots for $872M in a blockbuster IPO

Pharma contracting giant Catalent has jumbo-sized its Wall Street ambitions, filing to go public in an IPO that would bring in about $872 million at its midpoint.

China's HD Bio teams with Marshall U. for cancer R&D

Chinese clinical research outfit HD Biosciences has struck a deal with Marshall University to collaborate on cancer drug development, sharing costs and risks in hopes of commercializing new therapies.

NCI backs out of a $34M deal with Charles River, putting jobs in jeopardy

The National Cancer Institute is terminating a $34 million mouse-model contract with Charles River Laboratories, possibly imperiling jobs at one of the CRO's Maryland outposts.

CMOs eye Russia for growth

Russia is striving to produce domestically 50% of the drugs sold in the country, and, to do so, it's encouraging global manufacturers to buy, build or rent facilities there.

InVentiv joins a nonprofit effort to make trials more efficient

CRO inVentiv Health has agreed to share its expertise with the nonprofit Alliance for Clinical Research Excellence and Safety (ACRES), working to develop global standards for clinical trials.

Risk-sharing CRO Ergomed banks $18.9M and awaits a U.K. IPO

U.K. researcher Ergomed is set to debut on the London stock exchange, raising £11 million ($18.9 million) to wrap up an acquisition and expand its global footprint.

U.K. CRO emerges from $100M in deals with plans for more M&A

With the help of U.K. investor Equistone, newly minted CRO Concept Life Sciences has snapped up three contractors and set out to do business as a conglomerate, scouting for clients looking to outsource scientific work.

Nicox's $120M Aciex deal gives CRO Ora a bigger partner

Ophthalmic CRO Ora is inheriting a relationship with drugmaker Nicox after the French outfit agreed to buy Aciex Therapeutics, a Boston-based biotech at work on eye treatments.

AMRI eyes a big year after completing another buyout

Contract developer AMRI has closed its $110 million acquisition of drug manufacturer Oso Biopharmaceuticals, its second deal this year and one the company believes will help pad its annual revenue.

Quintiles extends its commercial capabilities with Encore buyout

Quintiles has wrapped up its acquisition of healthcare analytics provider Encore, part of the CRO's push to grow its post-market services.

BioOutsource plots a U.S. expansion with eyes on biosimilars

Scottish contractor BioOutsource is planning a deeper dive into the U.S. market for development services, setting sights on a new lab in Massachusetts to serve its American clientele.

Catalent eyes a Japanese expansion after 40 years in the country

Contract developer Catalent is planning to open a new facility in Japan as it marks 40 years doing business in the country, looking to expand its scale in R&D and manufacturing.

Parexel eyes the Middle East with its latest CRO buyout

Parexel International is looking to broaden its presence in the Middle East and North Africa, snapping up Turkish CRO Atlas Medical Services.

Recipharm and CTC unite for early-stage trials

Contract developer Recipharm and CTC Clinical Trial Consultants are joining forces to offer combined Phase I services, pooling their capabilities in manufacturing and trial conduction.

Evotec pockets a payment in its Boehringer partnership

German contractor Evotec has notched another milestone in its years-long arrangement with Boehringer Ingelheim, netting €1 million ($1.4 million) after moving a respiratory compound into preclinical study.